Drug General Information
Drug ID
D09UKH
Former ID
DCL001257
Drug Name
XL550
Indication Type 2 diabetes [ICD9: 250; ICD10:E11] Phase 1 [550638]
Company
Exelixis; Daiichi-Sankyo
Target and Pathway
Target(s) Mineralocorticoid receptor Target Info Antagonist [550638]
KEGG Pathway Aldosterone-regulated sodium reabsorption
PathWhiz Pathway Kidney Function
WikiPathways ACE Inhibitor Pathway
References
Ref 550638Clinical pipeline report, company report or official report of Exelixis (2011).
Ref 550638Clinical pipeline report, company report or official report of Exelixis (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.